Digital preclinical science founded in problem definition, integration, and continuous learning

DiPS — the Digital Preclinical Society — is the first professional society that aims to collaboratively leverage the power of digital capabilities. We are a member-based, multi-stakeholder, cross-Atlantic body. Together, we convene scientists, regulators, sponsors, CROs, and technology providers around one question: does the evidence predict the clinic? We federate. We codify. We convene. Where others lead, we reinforce. Where the field lacks a bridge, we build it.

You do not join DiPS for access. You join to build the discipline.

As a member, you shape the standards that sponsors, CROs, and regulators will use across digital preclinical science. You sit in working groups alongside FDA, EMA, ICH, OECD, and PMDA participants — we draft our standards with regulators in the room, not to them after the fact. You read, challenge, and co-author the consensus outputs — handbooks, templates, benchmark datasets, case studies — before they enter the wider field.

Founding members do more. The founding board and the charter signatories set the terms for everything that follows. Founding seats close once the founding board is seated.

One caveat — we are a Society, not a vendor. We do not sell productivity. We build the discipline you will practice in.

Start with the charter. Read it. If the argument holds, sign it. Then pick your on-ramp — seven exist, one will fit you:

• Scientist at the preclinical-to-clinical interface. Sign the charter. Join the founding forum series.
• Leader of preclinical safety, toxicology, pharmacology, efficacy, or translational research at a pharma or biotech. Join the founding partner circle.
• CRO, CDMO, vivarium technology organization, data standards body, or digital platform company. Bring a use case, not a product pitch.
• Regulator — FDA, EMA, ICH, OECD, PMDA, or another public authority. Participate as a regulator-member, free of charge.
• Adjacent organization — DIVA, Pistoia Alliance, 3Rs Collaborative, DiMe, FELASA, CDISC, or a discipline-specific society. Open a partnership pathway or memorandum of understanding.
• None of the above, but you care about preclinical evidence reaching patients reliably. Attend the founding forum series.
• You want the discipline delivered to you weekly. Subscribe to The Digital Record.

Year one is field-definition, not working groups. DiPS focuses on four foundation products: a definition and scope statement; an opportunity and value proposition map; a founding forum series; and a foundational gaps and opportunities manuscript. Funded working groups begin only when the foundation products show where partner demand and field value are strongest. The founding forum series is the first table — aligned presenters, moderated roundtables, practical reading sessions. Regulators participate free of charge where agency rules permit. We draft with regulators in the room, not to them after the fact. We federate with adjacent organizations on both the in-vivo and the non-animal sides — DIVA, Pistoia Alliance, 3Rs Collaborative, DiMe, FELASA, CDISC, ICCVAM, NICEATM, EURL ECVAM, ASPIS, ONTOX, EUROoCS, the IQ Consortium MPS Affiliate, CAAT, and discipline-specific societies — through partnership pathways, not competition. Memoranda of understanding, not silos.

Members do not consume the field. They build it. Together, we codify the standards, draft the templates, and shape the consensus outputs that the field then adopts. The Digital Record — our weekly publication — tracks what we published, what we partnered on, what we learned, and what we changed our minds about. Three on-ramps, one direction: in front of the field because you helped define it.